Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cornucopian Capital is a venture capital firm founded in 2020 and based in Montclair, New Jersey. The firm is dedicated to advancing 'Medicine 3.0', a concept that emphasizes predictive, preventive, personalized, and participatory healthcare. This investment organization seeks to support companies that enhance healthspan, performance, and longevity through scientific knowledge and accessible technologies. Cornucopian Capital operates with a focus on long-term capital deployment, aiming to foster innovation in the health and wellness sectors.
As of now, Cornucopian Capital manages a small but focused portfolio of 12 companies, reflecting its strategy of high-conviction investments. The firm operates the Barnstorm Foundry, a venture studio dedicated to building startups in the food and health sectors. Collaborations with institutions such as the University of California, Davis, and the New Jersey Innovation Institute further enhance their capabilities in advancing metabolic health and connecting researchers with industry partners.
Cornucopian Capital invests in early-stage companies across several sectors, including healthcare, biotech, longevity, consumer products, and food-agtech. The firm provides funding at various early VC stages, from pre-seed and seed to Series A and B+, with initial check sizes ranging from $250,000 to $5 million. Their investment thesis emphasizes the integration of technology and scientific insight to improve patient-consumer engagement and health outcomes.
The firm specifically targets companies that align with their vision of 'Medicine 3.0', focusing on metabolic health and high-integrity consumer health products. Cornucopian Capital prefers to lead Seed and Series A rounds, participating opportunistically in later stages. Their approach is characterized by a commitment to long-term partnerships, allowing portfolio companies to benefit from sustained support as they navigate growth and innovation.
Cornucopian Capital's portfolio includes a diverse range of companies that exemplify their focus on healthcare innovation:
This portfolio reflects Cornucopian Capital's commitment to investing in companies that are at the forefront of healthcare innovation, particularly those that enhance healthspan and longevity.
Aryeh Ganz - Managing Partner. Aryeh is the founder of Cornucopian Capital and the architect of its investment thesis around Medicine 3.0. He has extensive experience in venture capital and healthcare innovation.
Jinny Choi - General Partner. Jinny brings a wealth of experience in healthcare investments and has a strong background in operational roles within the industry.
Rachelle Peluso - Operating Partner. Rachelle focuses on operational support for portfolio companies, leveraging her expertise in scaling health and wellness startups.
William Zhang - Senior Associate. William assists in deal sourcing and due diligence, contributing to the firm's investment strategy.
Matei Vaduva - Research Analyst. Matei conducts market research and analysis to support investment decisions.
Avi Rosenbaum - Venture Partner. Avi provides strategic insights and guidance based on his extensive experience in the healthcare sector.
Giovanni Battistini - Venture Partner. Giovanni focuses on identifying new investment opportunities and supporting portfolio companies.
Erich Veitenheimer III - Advisor. Erich offers advisory support on strategic initiatives and industry trends.
Justin Siegel, PhD - Advisor. Justin provides scientific insights and guidance, particularly in biotech and health innovation.
Phil Johnston - Advisor. Phil brings expertise in operational strategy and scaling businesses.
Joe Wang - Advisor. Joe focuses on technology integration and innovation within healthcare.
Tricia Ulricksen - Talent Partner. Tricia assists portfolio companies in building strong teams and organizational structures.
Cornucopian Capital operates several initiatives aimed at fostering innovation in healthcare:
What are Cornucopian Capital's investment criteria?
Cornucopian Capital focuses on early-stage companies in healthcare, biotech, longevity, consumer products, and food-agtech. They prefer to lead Seed and Series A rounds, with check sizes ranging from $250,000 to $5 million.
How can I pitch to Cornucopian Capital?
Founders can reach out through their website to inquire about pitching opportunities. A well-prepared pitch deck that aligns with their investment thesis on Medicine 3.0 is recommended.
What makes Cornucopian Capital different from other investors?
The firm emphasizes long-term partnerships and provides not only capital but also strategic guidance and access to a network of industry experts in health and wellness.
What is the geographic focus of Cornucopian Capital?
Cornucopian Capital primarily invests in North America, specifically within the United States.
What is the firm's approach to post-investment involvement?
Cornucopian Capital maintains a hands-on approach, offering operational support and strategic guidance to help portfolio companies navigate growth and innovation.
What is the typical follow-on investment behavior?
The firm participates opportunistically in later-stage rounds, focusing on companies that align with their long-term investment thesis.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.